Pönisch, W., Rozanski, M., Goldschmidt, H., Hoffmann, F. A., Boldt, T., Schwarzer, A., . . . Niederwieser, D. (2008). Combined bendamustine, prednisolone and thalidomide for refractory or relapsed multiple myeloma after autologous stem-cell transplantation or conventional chemotherapy: Results of a Phase I clinical trial. British journal of haematology, 143(2), . https://doi.org/10.1111/j.1365-2141.2008.07076.x
Chicago-Zitierstil (17. Ausg.)Pönisch, Wolfram, et al. "Combined Bendamustine, Prednisolone and Thalidomide for Refractory or Relapsed Multiple Myeloma After Autologous Stem-cell Transplantation or Conventional Chemotherapy: Results of a Phase I Clinical Trial." British Journal of Haematology 143, no. 2 (2008). https://doi.org/10.1111/j.1365-2141.2008.07076.x.
MLA-Zitierstil (9. Ausg.)Pönisch, Wolfram, et al. "Combined Bendamustine, Prednisolone and Thalidomide for Refractory or Relapsed Multiple Myeloma After Autologous Stem-cell Transplantation or Conventional Chemotherapy: Results of a Phase I Clinical Trial." British Journal of Haematology, vol. 143, no. 2, 2008, https://doi.org/10.1111/j.1365-2141.2008.07076.x.